[HTML][HTML] A glance at the development and patent literature of tecovirimat: the first-in-class therapy for emerging monkeypox outbreak

M Almehmadi, M Allahyani, AA Alsaiari… - Viruses, 2022 - mdpi.com
Monkeypox disease (MPX) is currently considered a global threat after COVID-19. European
Medicines Agency (EMA) approved Tecovirimat in capsule dosage form (200 mg) as the first …

[HTML][HTML] Selenium and COVID-19: A spotlight on the clinical trials, inventive compositions, and patent literature

MK Alshammari, W Fatima, RA Alraya… - Journal of Infection and …, 2022 - Elsevier
Selenium is an indispensable trace element for all living organisms. It is an essential
structural component of several selenium-dependent enzymes, which support the human …

[HTML][HTML] A vaccine construction against COVID-19-associated mucormycosis contrived with immunoinformatics-based scavenging of potential Mucoralean Epitopes

M Naveed, U Ali, MI Karobari, N Ahmed, RN Mohamed… - Vaccines, 2022 - mdpi.com
Mucormycosis is a group of infections, caused by multiple fungal species, which affect many
human organs and is lethal in immunocompromised patients. During the COVID-19 …

[HTML][HTML] COVID-19 associated mucormycosis–An emerging threat

CM Chao, CC Lai, WL Yu - Journal of Microbiology, Immunology and …, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) rapidly become a global threaten since its …

[HTML][HTML] The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects

AS Alshrari, SA Hudu, F Elmigdadi, M Imran - Biomedicines, 2023 - mdpi.com
Clostridioides difficile infection (CDI) is an urgent threat and unmet medical need. The
current treatments for CDI are not enough to fight the burden of CDI and recurrent CDI (r …

[HTML][HTML] Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature

M Imran, SA Khan, Abida, MK Alshammari, SM Alkhaldi… - Molecules, 2022 - mdpi.com
COVID-19 has had an impact on human quality of life and economics. Scientists have been
identifying remedies for its prevention and treatment from all possible sources, including …

Antioxidant, anti-inflammatory, and immunomodulatory roles of nonvitamin antioxidants in anti-SARS-CoV-2 therapy

AM Pisoschi, F Iordache, L Stanca… - Journal of Medicinal …, 2022 - ACS Publications
Viral pathologies encompass activation of pro-oxidative pathways and inflammatory burst.
Alleviating overproduction of reactive oxygen species and cytokine storm in COVID-19 is …

[PDF][PDF] COVID-19 and mucormycosis (black fungus): an epidemic within the pandemic

RS Gambhir, A Aggarwal, A Bhardwaj… - Roczniki …, 2021 - bibliotekanauki.pl
The second wave of the COVID-19 pandemic has affected India significantly with country
reporting more than 400,000 cases in the month of May 2021 and health system almost …

[HTML][HTML] Development of therapeutic and prophylactic zinc compositions for use against COVID-19: A glimpse of the trends, inventions, and patents

M Imran, W Fatima, AK Alzahrani, N Suhail… - Nutrients, 2022 - mdpi.com
Zinc is an essential nutrient for human health; it is involved in the catalytic, structural, and
regulatory functions of the human cellular system. Different compositions of zinc, as well as …

Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: A patent review from 1998 to 2021

M Imran, SA Khan, Abida, AS Alshrari… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Leishmaniasis is a neglected tropical infectious disease. The available limited
therapeutic options for leishmaniasis are inadequate due to their poor pharmacokinetic …